LakeShore Biopharma Co., Ltd. (NASDAQ:LSB) Short Interest Up 1,175.5% in July

LakeShore Biopharma Co., Ltd. (NASDAQ:LSB) saw a large growth in short interest in the month of July. As of July 15th, there was short interest totaling 182,400 shares, agrowthof1,175.5% from the June 30th total of 14,300 shares. Approximately2.6% of the shares of the company are sold short. Based on an average daily volume of 275,600 shares, the short-interest ratio is presently 0.7 days. Based on an average daily volume of 275,600 shares, the short-interest ratio is presently 0.7 days. Approximately2.6% of the shares of the company are sold short.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in LakeShore Biopharma stock. Orbimed Advisors LLC acquired a new position in shares of LakeShore Biopharma Co., Ltd. (NASDAQ:LSB) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 140,428 shares of the company’s stock, valued at approximately $486,000. Orbimed Advisors LLC owned approximately 1.51% of LakeShore Biopharma as of its most recent filing with the Securities and Exchange Commission. Institutional investors own 52.64% of the company’s stock.

LakeShore Biopharma Stock Performance

LSB stock opened at $0.73 on Monday. The company has a current ratio of 1.02, a quick ratio of 0.75 and a debt-to-equity ratio of 0.05. LakeShore Biopharma has a fifty-two week low of $0.70 and a fifty-two week high of $8.60. The stock has a fifty day moving average of $1.03 and a 200-day moving average of $1.63.

LakeShore Biopharma Company Profile

LakeShore Biopharma Co, Ltd. engages in the provision of discovering, developing, manufacturing, and commercializing vaccines and therapeutic biologics for infectious diseases and cancer. It focuses on developing PIKA technology platform. It operates through the People’s Republic of China and Other Countries or Regions.